CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sanara Medtech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sanara Medtech Inc
1200 Summit Avenue, Suite 414
Phone: (817) 529-2300p:817 529-2300 FORT WORTH, TX  76102  United States Ticker: SMTISMTI
Business Summary
Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical markets. It primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its soft tissue repair products include, among other products, the lead product, CellerateRX Surgical Powder, a hydrolyzed collagen that aids in the management of surgical wounds, BIASURGE Advanced Surgical Solution, a sterile no-rinse, advanced surgical solution used for wound irrigation and TEXAGEN Amniotic Membrane Allograft, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement if needed. Its bone fusion products include, among other products, BiFORM Bioactive Moldable Matrix, ACTIGEN Verified Inductive Bone Matrix, and ALLOCYTE Plus Advanced Viable Bone Matrix.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
8011 Offices and clinics of doctors of medicine
6794 Patent owners and lessors

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board Ronald T.Nixon 70 9/15/2025 3/1/2019
President, Chief Executive Officer, Director Seth D.Yon 51 9/15/2025 4/1/2025
Chief Financial Officer Elizabeth B.Taylor 50 1/15/2025 1/15/2025
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Wound Care Innovations, LLC 6400 North Andrews Avenue Fort Lauderdale FL United States
Scendia Biologics LLC 111 W Jefferson St Orlando FL United States
Precision Healing, Inc. 275 Washington Street Newton MA United States

Business Names
Business Name
CarePICS, LLC
Cellerate, LLC
Health Plus, LLC
17 additional Business Names available in full report.

General Information
Number of Employees: 108 (As of 12/31/2025)
Outstanding Shares: 9,188,035 (As of 8/7/2026)
Shareholders: 290
Stock Exchange: NASD
Federal Tax Id: 592220004


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, October 4, 2026